40% of patients with bone marrow involvement responded compared to 59% of patients with no bone marrow involvement (p=0.0186).
Luuüdi haaratusega patsientidest reageeris ravimile 40% ja luuüdi haaratuseta patsientidest 59% (p=0, 0186).